SJG-136 in Treating Patients With Advanced Solid Tumors

Summary

This phase I trial is studying the side effects and best dose of SJG-136 in treating patients with advanced solid tumors. Drugs used in chemotherapy, such as SJG-136, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Timeline

Start

2004-11

Primary completion

2007-02

Completion

—

Drugs

Indications